Depreciation in USD of CRISPR Therapeutics AG from 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
CRISPR Therapeutics AG quarterly/annual Depreciation history and growth rate from 2014 to Q3 2025.
  • CRISPR Therapeutics AG Depreciation for the quarter ending September 30, 2025 was $4.4M, a 8.33% decline year-over-year.
  • CRISPR Therapeutics AG Depreciation for the twelve months ending September 30, 2025 was $18.5M, a 4.15% decline year-over-year.
  • CRISPR Therapeutics AG annual Depreciation for 2024 was $19.2M, a 3.03% decline from 2023.
  • CRISPR Therapeutics AG annual Depreciation for 2023 was $19.8M, a 17.8% decline from 2022.
  • CRISPR Therapeutics AG annual Depreciation for 2022 was $24.1M, a 34.6% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

CRISPR Therapeutics AG Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $18.5M $4.4M -$400K -8.33% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $18.9M $4.6M -$200K -4.17% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-04
Q1 2025 $19.1M $4.7M -$100K -2.08% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 $19.2M $4.8M -$100K -2.04% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-11
Q3 2024 $19.3M $4.8M -$100K -2.04% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 $19.4M $4.8M -$200K -4% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-04
Q1 2024 $19.6M $4.8M -$200K -4% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q4 2023 $19.8M $4.9M -$900K -15.5% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-11
Q3 2023 $20.7M $4.9M -$100K -2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $20.8M $5M -$2.3M -31.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $23.1M $5M -$1M -16.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $24.1M $5.8M -$500K -7.94% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-11
Q3 2022 $24.6M $5M -$300K -5.66% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $24.9M $7.3M +$3.7M +103% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $21.2M $6M +$3.3M +122% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $17.9M $6.3M +$3.8M +152% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 $14.1M $5.3M +$3M +130% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $11.1M $3.6M +$1.4M +63.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $9.7M $2.7M +$600K +28.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $9.1M $2.5M +$1.1M +78.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $8M $2.3M +$1M +76.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $7M $2.2M +$1.2M +120% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $5.8M $2.1M +$1.1M +110% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-27
Q4 2019 $4.7M $1.4M +$400K +40% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-15
Q3 2019 $4.3M $1.3M +$500K +62.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-28
Q2 2019 $3.8M $1M +$100K +11.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-27
Q1 2019 $3.7M $1M +$200K +25% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-28
Q4 2018 $3.5M $1M +$200K +25% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-16
Q3 2018 $3.3M $800K $0 0% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-28
Q2 2018 $3.3M $900K +$200K +28.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-29
Q1 2018 $3.1M $800K +$100K +14.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 $3M $800K +$300K +60% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-12
Q3 2017 $2.7M $800K +$600K +300% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $2.1M $700K +$600K +600% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $1.5M $700K +$600K +600% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $900K $500K Oct 1, 2016 Dec 31, 2016 10-K 2019-02-25
Q3 2016 $200K +$173K +641% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $100K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $100K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q3 2015 $27K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-22

CRISPR Therapeutics AG Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $19.2M -$600K -3.03% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-11
2023 $19.8M -$4.3M -17.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-11
2022 $24.1M +$6.2M +34.6% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-11
2021 $17.9M +$8.8M +96.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 $9.1M +$4.4M +93.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $4.7M +$1.2M +34.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 $3.5M +$500K +16.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-16
2017 $3M +$2.1M +233% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-12
2016 $900K +$800K +800% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-25
2015 $100K +$100K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.